aTyr Pharma (LIFE) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
UPDATE: Citi Downgrades aTyr Pharma (LIFE) to Sell
May 14, 2018 4:18 PM EDT(Updated - May 15, 2018 5:30 AM EDT)
(updated to add analyst comment)
Citi downgraded aTyr Pharma (NASDAQ: LIFE) from Neutral to Sell with a price target of $1.00 (from $4.00).
Analyst Joel Beatty believes the probability of success for lead... More
aTyr Pharma (LIFE) PT Lowered to $2 at BMO Capital
May 14, 2018 12:57 PM EDTBMO Capital lowered its price target on aTyr Pharma (NASDAQ: LIFE) to $2.00 (from $4.00) while maintaining a Market Perform rating.
Analyst Matthew Luchini commented, "We remain Market Perform rated following discontinuation of the ORCA I/O program, and restructuring announcement. While the restructuring... More
